JE
JMAC Enterprises Portfolio holdings
AUM
$467M
1-Year Return
12.91%
This Quarter Return
-5.33%
1 Year Return
+12.91%
3 Year Return
+54.99%
5 Year Return
–
10 Year Return
–
AUM
$356M
AUM Growth
-$32.1M
(-8.3%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
36.96%
Holding
183
New
7
Increased
97
Reduced
39
Closed
11
Top Buys
| 1 |
Apple
AAPL
|
$471K |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$374K |
| 3 |
CVS Health
CVS
|
$367K |
| 4 |
Kroger
KR
|
$354K |
| 5 |
Entergy
ETR
|
$315K |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$2.01M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$1.62M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$1.49M |
| 4 |
Invesco QQQ Trust
QQQ
|
$1.47M |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
$1.27M |
Sector Composition
| 1 | Healthcare | 9.71% |
| 2 | Technology | 4.85% |
| 3 | Consumer Staples | 2.99% |
| 4 | Consumer Discretionary | 2.27% |
| 5 | Financials | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Accenture
ACN
$159B
| $273K | 0.08% |
1,061
+33
| +3% | +$8.49K |
|
152
Archer Daniels Midland
ADM
$30.2B
| $264K | 0.07% |
3,282
+100
| +3% | +$8.04K |
|
153
AstraZeneca
AZN
$253B
| $261K | 0.07% |
+4,757
| New | +$261K |
|
154
Southern Company
SO
$101B
| $260K | 0.07% |
3,821
+17
| +0.4% | +$1.16K |
|
155
Caterpillar
CAT
$198B
| $259K | 0.07% |
1,579
+59
| +4% | +$9.68K |
|
156
Intel
INTC
$107B
| $257K | 0.07% |
9,992
| – | – |
|
157
ASML
ASML
$307B
| $253K | 0.07% |
609
| – | – |
|
158
Novo Nordisk
NVO
$245B
| $232K | 0.07% |
4,656
| – | – |
|
159
CMS Energy
CMS
$21.4B
| $221K | 0.06% |
3,792
+800
| +27% | +$46.6K |
|
160
Ferrari
RACE
$87.1B
| $216K | 0.06% |
1,166
| – | – |
|
161
ResMed
RMD
$40.6B
| $212K | 0.06% |
971
-335
| -26% | -$73.1K |
|
162
Mondelez International
MDLZ
$79.9B
| $210K | 0.06% |
3,834
+2
| +0.1% | +$110 |
|
163
PACCAR
PCAR
$52B
| $209K | 0.06% |
+3,750
| New | +$209K |
|
164
TSMC
TSM
$1.26T
| $206K | 0.06% |
3,001
-1,405
| -32% | -$96.4K |
|
165
EPAM Systems
EPAM
$9.44B
| $205K | 0.06% |
+565
| New | +$205K |
|
166
Hershey
HSY
$37.6B
| $205K | 0.06% |
931
| – | – |
|
167
Applied Materials
AMAT
$130B
| $202K | 0.06% |
2,466
-2
| -0.1% | -$164 |
|
168
iShares Biotechnology ETF
IBB
$5.8B
| $200K | 0.06% |
1,706
| – | – |
|
|
BCLI
169
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $179K | 0.05% |
2,695
-334
| -11% | -$22.2K |
|
170
Ford
F
$46.7B
| $178K | 0.05% |
15,874
+1,412
| +10% | +$15.8K |
|
171
Eledon Pharmaceuticals
ELDN
$162M
| $151K | 0.04% |
54,538
| – | – |
|
172
Moleculin Biotech
MBRX
$11.4M
| $14K | ﹤0.01% |
875
| – | – |
|
173
Alcon
ALC
$39.6B
| – | – |
-3,163
| Closed | -$221K |
|
174
Comcast
CMCSA
$125B
| – | – |
-5,746
| Closed | -$225K |
|
175
DuPont de Nemours
DD
$32.6B
| – | – |
-3,849
| Closed | -$214K |
|